Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
31 minute read
  • Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights
Today, 6:49 PM
  On Wednesday, 479 stocks made new 52-week lows.

AAP

Read More
16 minute read
  • Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights
Today, 6:49 PM
  On Wednesday, 258 companies hit new 52-week lows.

ACB

Read More
18 minute read
  • Options

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights
Today, 6:49 PM
  Thursday's session saw 329 companies set new 52-week lows.

ABNB

Read More
17 minute read
  • Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights
Today, 6:49 PM
  During Friday's trading, 293 companies set new 52-week lows.

ACEL

Read More
1 minute read
  • News

Reported Late Monday, Pasithea Therapeutics Postpones Special Meeting Until December 9, 2022

By Benzinga Newsdesk
Today, 6:49 PM
Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system

KTTA

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights
Today, 6:49 PM
Gainers

ABOS

Read More
1 minute read
  • Biotech
  • Exclusives
  • General
  • Health Care
  • M&A
  • Market-Moving Exclusives
  • News
  • Penny Stocks

EXCLUSIVE: Pasithea Bolsters CNS-Focused Pipeline With AlloMek Therapeutics Acquisition

By Vandana Singh
Today, 6:49 PM
Pasithea Therapeutics Corp (NASDAQ: KTTA) has acquired AlloMek Therapeutics LLC, a privately-held biotechnology company, 

KTTA

Read More
3 minute read
  • News

Investor Group Sends Letter To Pasithea Therapeutics’ Board of Directors; Urges Co To Hold Special Meeting Without Further Delay

By Benzinga Newsdesk
Today, 6:49 PM
Investor Group Sends Letter to Pasithea Therapeutics' Board of Directors  Urges the Company to Honor Stockholders' Will and Hold the Special Meeting Without Further Delay Expresses Disappointment with the

KTTA

Read More
1 minute read
  • Movers
  • Trading Ideas

Pasithea Therapeutics Shares Move Higher On Increased Volume, Traders Circulate Benzinga Article Highlighting Co.’s Multiple Sclerosis Vaccine Efficacy Potential For Monkeypox; BZ Note: Article In Circulation Was Published 6 Days Ago

By Michael Horton
Today, 6:49 PM
https://www.benzinga.com/general/biotech/22/08/28448364/exclusive-pasitheas-multiple-sclerosis-vaccine-candidate-shows-efficacy-in-animal-studies-with-po

KTTA

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights
Today, 6:49 PM
Gainers

ADXN

Posts navigation

1 2 … 8 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service